SCHEMBL3142808

SCHEMBL3142808

COc1cccc2c(CC(N)=O)coc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 2/20 0.52
PSMB8 P28062 1/20 0.52
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
HPGD P15428 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
ICMT O60725 1/20 0.42
TBXA2R P21731 4/20 0.41
PTGIR P43119 4/20 0.41
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10671152 0.89 PSMB5 (0.52) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL4138516 0.87 PSMB5 (0.53) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL7948483 0.87 PSMB8 (0.56) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL7956758 0.86 PSMB5 (0.55) PSMB5PSMB8ALDH1A1KMT2ALMNA
Hydrochloric Acid SCHEMBL10671160 0.86 PSMB8 (0.55) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL21836357 0.84 PSMB5 (0.54) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL21836382 0.83 PSMB5 (0.50) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL6839194 0.82 PSMB5 (0.49) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL806348 0.82 ALDH1A1 (0.54) PSMB5PSMB8ALDH1A1KMT2ALMNA
SCHEMBL3257949 0.81 SMN1; SMN2 (0.50) PSMB5PSMB8ALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125683-B1 3-BENZOFURANYL-4-INDOLYL-MALEIMIDES AS POTENT GSK-3 INHIBITORS FOR NEURODEGENERATIVE DISORDERS UNIV ILLINOIS (US) 2013-10-23 EP disclosed
US-8207216-B2 Benzofuran-3-yl(indol-3-yl) maleimides as potent GSK3 inhibitors THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-06-26 US disclosed
US-20100004308-A1 Benzofuran-3-yl(indol-3-yl) Maleimides as Potent GSK3 Inhibitors THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS, A BODY CORPORATE AND POLITIC OF THE STATE OF ILLINOIS 2010-01-07 US disclosed
EP-2125683-A1 3-BENZOFURANYL-4-INDOLYL MALEIMIDES AS POTENT GSK3 INHIBITORS FOR NEUROGENERATIVE DISORDERS The Board of Trustees of the University of Illinois (US) 2009-12-02 EP disclosed
WO-2008077138-A1 3-BENZOFURANYL-4-INDOLYL MALEIMIDES AS POTENT GSK3 INHIBITORS FOR NEUROGENERATIVE DISORDERS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2008-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004308-A1 Benzofuran-3-yl(indol-3-yl) Maleimides as Potent GSK3 Inhibitors GSK3B, GSK3A, GSKIP PSMB5 1509/4885PSMB8 3058/4885ALDH1A1 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.